Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    ancer diagnoses are on the rise

    Cancer Diagnoses are on the Rise, yet Prices of Key Medications Remain Staable: Nadda


    Finance Outlook India Team | Friday, 26 July 2024

    Health Minister JP Nadda said on Friday that the government is making every effort to ensure that cancer patients have access to reasonable and accessible treatment as the number of cases in India increases. Responding to supplementary questions during Question Hour in the Lok Sabha, Nadda stated that the government made every effort to ensure that patients get inexpensive and accessible care.

    "The number of cancer cases is going up, it is increasing by almost 2.5 per cent every year," Nadda told the crowd. He stated that occurrences of oral and lung cancer in males are increasing, while more women are developing breast cancer.

    According to Nadda, over 1.55 million cancer cases are documented each year. "There is a list of 131 important cancer drugs in Schedule 1, which are monitored and their prices are determined by the government. "These are the commonly used medicines," Nadda stated.

    He claimed that the pricing restriction saved patients around Rs 294 crore in total. "There are 28 combinations, which are not in this list but the NPPA (National Pharmaceutical Pricing Authority) and the government have controlled their pricing as well. We have tried to make cancer drugs affordable," he said.

    Responding to another question on healthcare facilities, Nadda stated that the government was aware of the situation and that medical colleges were being expanded to accommodate more physicians. "There should be a balance between quality and quantity in medical education. We are attempting to go as quickly as possible while not compromising the quality of medical doctors," he stated.

    Nadda informed the House that the number of medical schools has increased from 387 in 2014 to 731 currently, while the number of MBBS seats has increased from 51,348 to 1,12,112 (1.12 lakh) over the same period. The number of postgraduate places for medical students has increased from 31,185 in 2014 to 72,627 now, he said.



    Read More:

    Piyush Goyal Announces Rs 10,000 Crore Fund of Funds for Startups

    Ashika Institutional, MOFSL & Bajaj Broking Markets Closing Commentary

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us